Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature
In order to study alternatives at the tissue biopsy to study EGFR status in NSCLC patients, we evaluated three different liquid biopsy platforms (plasma, urine and exhaled breath condensate, EBC). We also reviewed the literature of the cfDNA biological sources other than plasma and compared our resu...
Saved in:
Main Authors: | Michela Verzè, Roberta Minari, Letizia Gnetti, Paola Bordi, Alessandro Leonetti, Agnese Cosenza, Leonarda Ferri, Maria Majori, Massimo De Filippo, Sebastiano Buti, Donatello Gasparro, Rita Nizzoli, Cinzia Azzoni, Lorena Bottarelli, Anna Squadrilli, Paola Mozzoni, Marcello Tiseo |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/baf6dfbf7bf446ec935f7672e54ef210 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Highly sensitive detection of driver mutations from cytological samples and cfDNA in lung cancer
by: Kazutaka Fujita, et al.
Published: (2021) -
Fragmentomic cfDNA Patterns in Noninvasive Prenatal Testing and Beyond
by: Kavish Kohabir, et al.
Published: (2021) -
Validating quantitative PCR assays for cfDNA detection without DNA extraction in exercising SLE patients
by: Elmo W. I. Neuberger, et al.
Published: (2021) -
Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients
by: Xiaorong Zhou, et al.
Published: (2021) -
Oncological evaluation in the perioperative period using cfDNA with BRAF V600E mutation in patients with colorectal cancer
by: Keita Tanaka, et al.
Published: (2021)